- In May 2024, ResMed Inc. launched its AirFit F40 full-face mask, an ultra-compact non-invasive ventilation mask designed for enhanced patient comfort and improved seal performance. This new addition to ResMed’s NIV mask portfolio aims to reduce skin irritation and pressure sores, while ensuring optimal fit, particularly for long-term respiratory patients in home care settings. The development highlights ResMed’s ongoing efforts to innovate patient-centric ventilation solutions
- In April 2024, Fisher & Paykel Healthcare announced the release of the Evora Full Mask, engineered for both hospital and home care use. The mask incorporates Dynamic Support Technology, which adapts to patient movements and improves sleep quality. With minimal touchpoints and improved patient compliance, this product showcases the company's focus on increasing comfort and efficiency in non-invasive ventilation therapy
- In March 2024, Philips Respironics, a division of Koninklijke Philips N.V., received expanded FDA clearance for its DreamWear Silicone Pillows Mask, enabling its use with a broader range of non-invasive ventilators. This clearance is expected to enhance the usability of DreamWear interfaces in both acute and chronic respiratory care, strengthening Philips' foothold in the NIV market
- In February 2024, Drägerwerk AG & Co. KGaA unveiled its next-generation NovaStar NIV face mask series, designed for compatibility with multiple ventilator models and offering improved airflow dynamics. The new line supports both adult ICU and home settings and includes masks with quick-release mechanisms to support rapid patient care in emergency scenarios
- In January 2024, VYAIRE Medical partnered with a leading telehealth platform to integrate real-time data tracking capabilities into its NIV mask systems. This advancement allows healthcare professionals to monitor patient adherence and ventilation metrics remotely, improving chronic disease management and facilitating early interventions in case of respiratory deterioration
